Prostate cancer stem cells

Despite the discovery over 60 years ago by Huggins and Hodges 1 that prostate cancers respond to androgen deprivation therapy, hormone-refractory prostate cancer remains a major clinical challenge. There is now mounting evidence that solid tumours originate from undifferentiated stem cell-like cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Lang, SH, Frame, FM, Collins, AT
Formato: Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd. 2009
Materias:
Invited Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2673349/
https://www.ncbi.nlm.nih.gov/pubmed/19040209
http://dx.doi.org/10.1002/path.2478
Descripción
Sumario:Despite the discovery over 60 years ago by Huggins and Hodges 1 that prostate cancers respond to androgen deprivation therapy, hormone-refractory prostate cancer remains a major clinical challenge. There is now mounting evidence that solid tumours originate from undifferentiated stem cell-like cells coexisting within a heterogeneous tumour mass that drive tumour formation, maintain tumour homeostasis and initiate metastases. This review focuses upon current evidence for prostate cancer stem cells, addressing the identification and properties of both normal and transformed prostate stem cells.

Ejemplares similares